This trial is active, not recruiting.

Condition infectious diseases
Sponsor InBios International, Inc.
Start date August 2012
End date September 2014
Trial size 300 participants
Trial identifier NCT02107677, DSC0094


This study assesses the specificity of DENV Detect™ NS1 ELISA versus standard reference tests (e.g. PCR or viral culture) for dengue diagnosis in the US.

DENV Detect™ NS1 ELISA serves as an aid in the clinical laboratory diagnosis of early stages of Dengue infection in patients with clinical symptoms consistent with Dengue infection. This test is intended to be used on sera obtained within the first 7 days of symptoms. DENV Detect™ NS1 ELISA and rapid test results (positive or negative) must be confirmed by testing with a reference standard test.

This study will use archived, leftover human serum samples that have been sequentially collected from areas non-endemic for Dengue infection. Each specimen must have been collected within the first 7 days of symptoms, and must be accompanied by clinical data demonstrating that the individual had symptoms consistent with Dengue infection. The samples will have no personally identifiable information.

ELISAs and reference tests will be performed by different operators who are laboratory staff members. These staff members, blinded to each other's results, will evaluate the samples from each method independently.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model case-only
Time perspective retrospective

Primary Outcomes

number of subjects with negative result
time frame: one day

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - All age groups and both sexes. - Serum samples collected within 1- 7 days of onset of symptoms consistent with Dengue virus infection. - Information must be available about symptoms, age, and sex of patients from which samples are collected. Exclusion Criteria: - Any sample(s) with linked personal identifiers or any sample for which personal information can be discovered will be excluded.

Additional Information

Official title Determination of Estimated Specificity of DENV Detect NS1 ELISAs
Trial information was received from ClinicalTrials.gov and was last updated in April 2014.
Information provided to ClinicalTrials.gov by InBios International, Inc..